CyberKnife M6Series Offers Unmatched Clinical Capabilities and Increased Efficiency, Extending its Radiosurgical Accuracy to a Broader Field of Applications SUNNYVALE, Calif. , Nov. 1, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced
The TomoHDA™ System Delivers Faster, High Quality 3D Image-Guided Radiation Therapy to the Full Spectrum of Radiation Oncology Patients Company Showcases New CyberKnife® M6™ Series, Pending FDA 510(k) Clearance SUNNYVALE, Calif. and BOSTON, Oct.
Fifth Users' Meeting Highlights Efficacy of TomoTherapy® Treatment System and Widespread Acceptance Across the Region SUNNYVALE, Calif. , Oct. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical research on its TomoTherapy ®
SUNNYVALE, Calif. , Oct. 19, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its first quarter of fiscal 2013, ended September 30, 2012 on Wednesday, November 7, 2012 after the market closes.
2012 ASTRO Meeting Provides Multiple Opportunities to Learn about Accuray's Leading Radiation Oncology Treatment Solutions SUNNYVALE, Calif. , Oct. 18, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, will announce significant product news at the
SUNNYVALE, Calif. , Oct. 12, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that Euan S. Thomson has resigned as President and Chief Executive Officer and Director of the Board. Accuray's Board has appointed Joshua H.
SUNNYVALE, Calif. , Oct. 1, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 29, 2012 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in
Integration of TomoTherapy on Track; Company Preparing for Major Technology Releases SUNNYVALE, Calif. , Sept. 6, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the fourth quarter and fiscal year ended June
SUNNYVALE, Calif., Aug. 23, 2012 /PRNewswire via COMTEX/ --Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Euan S. Thomson , Ph.D., is scheduled to present at the Morgan Stanley Global Healthcare Conference
Physicians at Instituto Neurologico de Colombia (INDEC) Can Now Provide Cancer Patients a Pain-Free, Non-Invasive Treatment Option SUNNYVALE, Calif. , Aug. 2, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that doctors at Instituto
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
